<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Long interspersed nucleotide element 1 (LINE-1) hypomethylation is suggested to play a role in the progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>To assess intra-patient <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of LINE-1 methylation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and to understand its biological relevance in invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, we evaluated the LINE-1 methylation at multiple <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> sites </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, the influence of stromal cell content on the measurement of LINE-1 methylation in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue was analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Formalin-fixed paraffin-embedded <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> tissue was obtained from 48 CRC patients </plain></SENT>
<SENT sid="4" pm="."><plain>Matched adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> colon tissue, <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> were obtained from 12, 18 and 7 of these patients, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Three different areas were microdissected from each <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and included the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> center and invasive front </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> mucosal and stromal cells were also microdissected for comparison with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>The microdissected samples were compared in LINE-1 methylation level measured by multicolor MethyLight assay </plain></SENT>
<SENT sid="8" pm="."><plain>The assay results were also compared between microdissected and macrodissected tissue samples </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: LINE-1 methylation within <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> showed no significant intra-tumoral <z:hpo ids='HP_0001425'>heterogeneity</z:hpo>, with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> center and invasive front showing identical methylation levels </plain></SENT>
<SENT sid="10" pm="."><plain>Moreover, no difference in LINE-1 methylation was observed between the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and lymph node and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> from the same patient </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> cells showed significantly less LINE-1 methylation compared to adjacent stromal and <z:mpath ids='MPATH_458'>normal</z:mpath> mucosal epithelial cells </plain></SENT>
<SENT sid="12" pm="."><plain>Consequently, LINE-1 methylation was significantly lower in microdissected samples compared to macrodissected samples </plain></SENT>
<SENT sid="13" pm="."><plain>A trend for less LINE-1 methylation was also observed in more advanced stages of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: LINE-1 methylation shows little intra-patient <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0001425'>heterogeneity</z:hpo>, indicating the suitability of its use for molecular diagnosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>The methylation is relatively stable during <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression, leading us to propose a new concept for the association between LINE-1 methylation and disease stage </plain></SENT>
</text></document>